Adult patients who present with papilloedema and symptoms of raised intracranial pressure need urgent multidisciplinary assessment including neuroimaging, to exclude life-threatening causes. Where there is no apparent underlying cause for the raised intracranial pressure, patients are considered to have idiopathic intracranial hypertension (IIH). The incidence of IIH is increasing in line with the global epidemic of obesity. There are controversial issues in its diagnosis and management. This paper gives a practical approach to assessing patients with papilloedema, its investigation and the subsequent management of patients with IIH.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Fifteen-minute consultation: the child with idiopathic intracranial hypertension
- Rapidly progressive vision loss due to fulminant idiopathic intracranial hypertension: a diagnostic and management dilemma
- Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management
- The swollen optic nerve: an approach to diagnosis and management
- Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension
- Diagnosis and management of benign intracranial hypertension
- Chiari type 1 malformation in a pseudotumour cerebri patient: is it an acquired or congenital Chiari malformation?
- Idiopathic intracranial hypertension: consensus guidelines on management
- Drugs used in childhood idiopathic or benign intracranial hypertension
- Guiding follow-up of paediatric idiopathic intracranial hypertension with optical coherence tomography